Secondary Prevention for Alzheimer Disease: Timing, Selection, and Endpoint of Clinical Trials

L. Vermunt

Secondary Prevention for Alzheimer Disease: Timing, Selection, and Endpoint of Clinical Trials

L. Vermunt

Research output: PhD Thesis › PhD-Thesis - Research and graduation internal

3070 Downloads (Pure)

Original language	English
Qualification	PhD
Awarding Institution	Vrije Universiteit Amsterdam
Supervisors/Advisors	Scheltens, P., Supervisor, - Visser, P.J., Co-supervisor, - Tijms, B.M., Co-supervisor, -
Award date	13 Mar 2020
Publication status	Published - 2020

Keywords

Alzheimer disease
trial design
preclinical
prodromal stages
disease modelling
autosomal dominant
structural covariance networks
imaging
csf
biomarkers

Access to Document

coverFinal published version, 71.6 KB
title pageFinal published version, 42.1 KB
abstract dutchFinal published version, 126 KB
abstract englishFinal published version, 319 KB
table of contentsFinal published version, 56 KB
complete dissertationFinal published version, 4.04 MB
chapter 1 IntroductionFinal published version, 251 KB
chapter 2Final published version, 685 KB
chapter 3Final published version, 379 KB
chapter 4Final published version, 3.91 MB
chapter 5 General summary and discussionFinal published version, 319 KB
appendix 6 the appendixFinal published version, 245 KB

Persistent URL (handle)

Persistent link

Cite this

@phdthesis{52a3025c0976429c8de88de197d6fa1c,

title = "Secondary Prevention for Alzheimer Disease: Timing, Selection, and Endpoint of Clinical Trials",

keywords = "Alzheimer disease, trial design, preclinical, prodromal stages, disease modelling, autosomal dominant, structural covariance networks, imaging, csf, biomarkers",

author = "L. Vermunt",

year = "2020",

language = "English",

type = "PhD-Thesis - Research and graduation internal",

school = "Vrije Universiteit Amsterdam",

}

TY - THES

T1 - Secondary Prevention for Alzheimer Disease

T2 - Timing, Selection, and Endpoint of Clinical Trials

AU - Vermunt, L.

PY - 2020

Y1 - 2020

KW - Alzheimer disease

KW - trial design

KW - preclinical

KW - prodromal stages

KW - disease modelling

KW - autosomal dominant

KW - structural covariance networks

KW - imaging

KW - csf

KW - biomarkers

M3 - PhD-Thesis - Research and graduation internal

ER -